中国医师进修杂志
中國醫師進脩雜誌
중국의사진수잡지
CHINESE JOURNAL OF POSTGRADUATES OF MEDICINE
2013年
26期
9-11
,共3页
蔡越飞%马燕华%王有枝%钟胜%谭小明%梁俊生
蔡越飛%馬燕華%王有枝%鐘勝%譚小明%樑俊生
채월비%마연화%왕유지%종성%담소명%량준생
肝性脑病%乳果糖%门冬氨酸鸟氨酸
肝性腦病%乳果糖%門鼕氨痠鳥氨痠
간성뇌병%유과당%문동안산조안산
Hepatic encephalopathy%Lactulose%Ornithine aspartate
目的 观察门冬氨酸鸟氨酸(OA)联合乳果糖对预防和治疗改良经皮经肝穿刺改良式肝内门体静脉分流术(TiPS)后肝性脑病的临床疗效.方法 选择因肝硬化门静脉高压行改良TIPS治疗的56例患者,术后均给予静脉滴注OA及口服乳果糖,观察术后肝性脑病的发生及血氨变化情况.对发生肝性脑病的患者,静脉滴注治疗剂量的OA及口服乳果糖,观察OA联合乳果糖治疗肝性脑病的效果及治疗前后血氨的变化.结果 56例患者在改良TIPS术后预防性使用OA及乳果糖情况下,均未见肝性脑病发生.停用OA及乳果糖后,有5例发生肝性脑病,发病率为8.93%(5/56).改良TIPS术后患者的血氨较术前升高[(88.2±23.0)μmol/L比(43.1±19.2)μmol/L],差异有统计学意义(P<0.05).5例肝性脑病患者经OA联合乳果糖治疗(联合用药平均治疗时间7d)后,均治愈,5例患者应用OA联合乳果糖治疗后血氨较治疗前显著降低[(69.1±14.1)μmol/L比(139.2±15.8)μmol/L],差异有统计学意义(P<0.05).结论 OA联合乳果糖可以预防和治疗改良TIPS后肝性脑病,其机制与降低血氨有关.
目的 觀察門鼕氨痠鳥氨痠(OA)聯閤乳果糖對預防和治療改良經皮經肝穿刺改良式肝內門體靜脈分流術(TiPS)後肝性腦病的臨床療效.方法 選擇因肝硬化門靜脈高壓行改良TIPS治療的56例患者,術後均給予靜脈滴註OA及口服乳果糖,觀察術後肝性腦病的髮生及血氨變化情況.對髮生肝性腦病的患者,靜脈滴註治療劑量的OA及口服乳果糖,觀察OA聯閤乳果糖治療肝性腦病的效果及治療前後血氨的變化.結果 56例患者在改良TIPS術後預防性使用OA及乳果糖情況下,均未見肝性腦病髮生.停用OA及乳果糖後,有5例髮生肝性腦病,髮病率為8.93%(5/56).改良TIPS術後患者的血氨較術前升高[(88.2±23.0)μmol/L比(43.1±19.2)μmol/L],差異有統計學意義(P<0.05).5例肝性腦病患者經OA聯閤乳果糖治療(聯閤用藥平均治療時間7d)後,均治愈,5例患者應用OA聯閤乳果糖治療後血氨較治療前顯著降低[(69.1±14.1)μmol/L比(139.2±15.8)μmol/L],差異有統計學意義(P<0.05).結論 OA聯閤乳果糖可以預防和治療改良TIPS後肝性腦病,其機製與降低血氨有關.
목적 관찰문동안산조안산(OA)연합유과당대예방화치료개량경피경간천자개량식간내문체정맥분류술(TiPS)후간성뇌병적림상료효.방법 선택인간경화문정맥고압행개량TIPS치료적56례환자,술후균급여정맥적주OA급구복유과당,관찰술후간성뇌병적발생급혈안변화정황.대발생간성뇌병적환자,정맥적주치료제량적OA급구복유과당,관찰OA연합유과당치료간성뇌병적효과급치료전후혈안적변화.결과 56례환자재개량TIPS술후예방성사용OA급유과당정황하,균미견간성뇌병발생.정용OA급유과당후,유5례발생간성뇌병,발병솔위8.93%(5/56).개량TIPS술후환자적혈안교술전승고[(88.2±23.0)μmol/L비(43.1±19.2)μmol/L],차이유통계학의의(P<0.05).5례간성뇌병환자경OA연합유과당치료(연합용약평균치료시간7d)후,균치유,5례환자응용OA연합유과당치료후혈안교치료전현저강저[(69.1±14.1)μmol/L비(139.2±15.8)μmol/L],차이유통계학의의(P<0.05).결론 OA연합유과당가이예방화치료개량TIPS후간성뇌병,기궤제여강저혈안유관.
Objective To observe the clinical effects of ornithine aspartate (OA) and lactulose on the prevention and treatment of hepatic encephalopathy for patients with portal hypertension after modified transjugular intrahepatic portosystemic shunt (TIPS).Methods Fifty-six patients with portal hypertension were treated by modified TIPS,OA and lactulose after the operation were given,the incidence of postoperative hepatic encephalopathy and the changes of blood ammonia were observed.Patients with hepatic encephalopathy after modified TIPS accepted therapeutic dosage of OA and lactulose,and the clinical effects of combined OA and lactulose on treatment of the hepatic encephalopathy after modified TIPS and changs of blood ammonia were evaluated as well.Results Prophylactic use of combined OA and lactulose after modified TIPS,there was no hepatic encephalopathy happened in 56 patients.Hepatic encephalopathy was seen in 5 patients after discontinuation of combined OA and lactulose,the incidence rate of hepatic encephalopathy was 8.93% (5/56).The level of blood ammonia in patients after modified TIPS was significanby higher than that before treatment [(88.2 ± 23.0) μ mol/L vs.(43.1 ± 19.2) μ mol/L,P < 0.05].Five patients with hepatic encephalopathy was improved quickly after given therapeutic dosage of OA and lactulose (the average treatment time was 7 d),and the level of blood ammonia was significantly lower than before treatment [(69.1 ± 14.1) p mol/L vs.(139.2 ± 15.8) μ mol/L,P< 0.05].Conclusion Combined OA and lactulose can effectively prevent and treat the hepatic encephalopathy after modified TIPS,its mechanism may be associated with reduction of blood ammonia level.